Acute hepatitis secondary to high-dose intravenous methylprednisolone

Gastroenterol Hepatol. 2018 Oct;41(8):508-509. doi: 10.1016/j.gastrohep.2017.09.002. Epub 2017 Nov 11.

[Article in English, Spanish]

Authors

Luzdivina Monteserín¹, Marcos Jiménez², Pedro Linares², Laura Rodríguez-Martín², Begoña Álvarez-Cuenllas², Concepción Álvarez-Cañas³, Francisco Jorquera²

Affiliations

¹ Servicio de Aparato Digestivo, Complejo Asistencial Universitario de León. Electronic address: monteserin.luz@gmail.com.
² Servicio de Aparato Digestivo, Complejo Asistencial Universitario de León.
³ Servicio de Anatomía Patológica, Complejo Asistencial Universitario de León.

PMID: 29132986
DOI: 10.1016/j.gastrohep.2017.09.002

No abstract available

Publication types

Case Reports
Review

MeSH terms

Chemical and Drug Induced Liver Injury / etiology*
Chemical and Drug Induced Liver Injury / pathology
Diagnosis, Differential
Drug Therapy, Combination
Female
Hearing Loss, Sudden / drug therapy
Hepatitis, Viral, Human / diagnosis
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects*
Methylprednisolone / administration & dosage
Methylprednisolone / adverse effects*
Middle Aged
Pregnenediones / therapeutic use

Substances

Immunosuppressive Agents
Pregnenediones
deflazacort
Methylprednisolone